Saturday 19 August 2017 | The view from Wall Street & Silicon Valley


Saturday January 18, 2014 | By The Closet Chartist

Questcor Pharma: Buy - January Bear Trap Rebound From Below $50 Targets As High As $80

While the process of recovery from the September 2012 dive on the daily chart of Questcor Pharma (QCOR) has been a relatively long one, most of the journey here back up from the sub $20 zone has been a consistent one. 

EPIC code: QCOR

Saturday January 18, 2014 | By The Closet Chartist

Galena Biopharma: Buy - November Price Channel Top Target Towards $10

 It may be something of an oversimplification to suggest that Galena Biopharma  (GALE) bears all the hallmarks of a classic recovery situation But it can be said that the daily chart in recent months ticks many of the boxes one would expect in terms of the way the price action has panned out. 

EPIC code: GALE

Saturday January 18, 2014 | By Staff Writer

1 More Sign of Manipulation in the Gold Market claims resource legend Eric Sprott

Eric Sprott is perhaps the world's best known precious metals investor. The claims he makes in his latest article are, to say the least, controversial.  Mr Sprott writes:

Gold

Thursday January 16, 2014 | By The Closet Chartist

JC Penney: Sell - Risk of Collapse to Sub $3

Judging by the charting position of JC Penney (JCP) during the past year it would appear that the market was initially trying to make up its mind regarding which way to go in terms of the price action. 


EPIC code: JCP

Thursday January 16, 2014 | By The Closet Chartist

Sodastream International: On balance Sell - Last Chance Saloon Support Line At $39

As Sodastream International (SODA) has been concerned we have been looking at a meltdown which has actually been some months in the making, but where the shares were initially looking at enjoying a happy 2013. 

EPIC code: SODA

Wednesday January 15, 2014 | By The Closet Chartist

Chelsea Therapeutics International – High Risk Buy

You will have to take my word that before looking at the updated daily chart of Chelsea Therapeutics (CHTP) and despite the two day close back below the 200 day moving average now at $2.77, it did appear that the shares were not a sell.

EPIC code: CHTP

Wednesday January 15, 2014 | By The Closet Chartist

Bank of America 2013 Price Channel Top Target Towards $18 within 6 weeks

At the end of the year shares of Bank of America (BAC) finished off on a high note, the story of calendar 2013 was rather more problematic. 

EPIC code: BAC

Wednesday January 15, 2014 | By Ross Norman of Sharps Pixley

The U.S. and Chinese Growth and their Different Impact on Gold Prices

The U.S. Comex gold futures rallied beyond $1,250 on Monday after last Friday's weak U.S. job report. Both the 10-year U.S. government bond yield and the Euro 10-year government bond yield fell about 10bp since last Thursday. 

Gold

Tuesday January 14, 2014 | By The Closet Chartist

SolarCity Corporation Buy Above $60 Zone Target $80 Plus

It is noticeable that the big impulsive moves as far as SolarCity (SCTY) last year came in May and October and both were similar in nature, and of similar magnitude. 

EPIC code: SCTY

Tuesday January 14, 2014 | By The Closet Chartist

Lululemon Athletica - Initial 2012 Price Channel Support but on balance still a short

Even more than a cursory glance at the price action of Lululemon Athletica (LULU) over the recent past will reveal that this is not a stock for widows or orphans, even those who may have been lucky enough to be short. 

EPIC code: LULU




About TopStockProphets

Contact Us

Advertise With Us

Send Us A Tip


Terms of Service

Privacy Policy

Cookie Policy


Forgot My Password

Forgot My Username

Resend Account Validation Token

Site by Everywhen